down arrow

Innovita Biological Technology Co., Ltd.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE100005Q14
CNY
31.12
-0.14 (-0.45%)

Dec 12

SHG

 Click here to see other stocks
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Comparison
Company
Score
Quality
Valuation
Financial
Technical
Innovita Biological Technology Co., Ltd.
Why is Innovita Biological Technology Co., Ltd. ?
1
With a fall in EPS of -49.88%, the company declared Very Negative results in Mar 25
  • The company has declared negative results for the last 2 consecutive quarters
  • The company has declared negative results in Dec 24 after 5 consecutive negative quarters
  • NET SALES(Q) At CNY 204.14 MM has Fallen at -27.11%
  • PRE-TAX PROFIT(Q) Fallen at -35.88%
  • NET PROFIT(Q) Fallen at -35.1%
2
Underperformed the market in the last 1 year
  • Even though the market (China Shanghai Composite) has generated returns of 12.36% in the last 1 year, the stock has hugely underperformed and has generate negative returns of -23.84% returns
stock-recommendationReal-Time Research Report
Verdict Report
How much should you sell?
  1. All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Innovita Biological Technology Co., Ltd. for you?

High Risk, Low Return

Absolute
Risk Adjusted
Volatility
Innovita Biological Technology Co., Ltd.
-23.84%
-0.50
39.56%
China Shanghai Composite
12.36%
0.86
14.45%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors
Factor
Value
Sales Growth (5y)
6.40%
EBIT Growth (5y)
28.97%
EBIT to Interest (avg)
100.00
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.96
Sales to Capital Employed (avg)
0.27
Tax Ratio
8.78%
Dividend Payout Ratio
30.94%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
128.44%
ROE (avg)
9.63%
stock-recommendationValuation
Valuation Scorecard stock-summary
stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary
Factor
Value
P/E Ratio
6
Industry P/E
Price to Book Value
0.46
EV to EBIT
-6.73
EV to EBITDA
-5.44
EV to Capital Employed
-5.34
EV to Sales
-1.96
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
Negative Capital Employed
ROE (Latest)
7.76%
stock-recommendationTechnicals
Technical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Mildly Bearish
Dow Theory
No Trend
No Trend
OBV
No Trend
No Trend
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
Analyse All Technical Factors stock-recommendation
stock-recommendationFinancial Trend
Financial Trend Scorecard stock-summary
stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

4What is working for the Company
DEBTORS TURNOVER RATIO(HY)

Highest at 11.24%

RAW MATERIAL COST(Y)

Fallen by -0.74% (YoY

DEBT-EQUITY RATIO (HY)

Lowest at -95.65 %

-21What is not working for the Company
NET SALES(Q)

At CNY 204.14 MM has Fallen at -27.11%

PRE-TAX PROFIT(Q)

Fallen at -35.88%

NET PROFIT(Q)

Fallen at -35.1%

Here's what is working for Innovita Biological Technology Co., Ltd.
Debtors Turnover Ratio
Highest at 11.24% and Grown
In each half year in the last five Semi-Annual periods
MOJO Watch
Company has been able to sell its Debtors faster

Debtors Turnover Ratio

Debt-Equity Ratio
Lowest at -95.65 %
in the last five Semi-Annual periods
MOJO Watch
The company has been reducing its borrowing as compared to equity capital

Debt-Equity Ratio

Raw Material Cost
Fallen by -0.74% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for Innovita Biological Technology Co., Ltd.
Net Sales
At CNY 204.14 MM has Fallen at -27.11%
Year on Year (YoY)
MOJO Watch
Near term sales trend is extremely negative

Net Sales (CNY MM)

Pre-Tax Profit
Fallen at -35.88%
Year on Year (YoY)
MOJO Watch
Near term Pre-Tax Profit trend is negative

Pre-Tax Profit (CNY MM)

Net Profit
Fallen at -35.1%
Year on Year (YoY)
MOJO Watch
Near term Net Profit trend is negative

Net Profit (CNY MM)

Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."